03.06.16

NUEsLETTER NO. 4: LETTER FROM THE CEO

Dear shareholder, Dear reader, Following requests from shareholders and our website visitors, I am now pleased to announce, that we have revised our website, and in particular the Investor section. We very much appreciate the feedback provided to us, and we hope that you will find information more easily accessible on the new site. All…

18.12.15

NUEsLETTER NO 3: LETTER FROM THE CEO

Dear new shareholder, First of all, thank you for having supported Nuevolution with its IPO, and rest assured that the company will invest the proceeds with great care in execution of its strategy. Nuevolution’s major pre-IPO and post-IPO shareholders SEB Venture Capital, SEB Ütvecklingsstiftelsen, Sunstone Capital and Industrifonden, management and board are all set, to…

22.10.15

NUEsLETTER NO 2: NUEVOLUTION LAUNCHES NEW WEBSITE

Focus on our new visual identity and new website. NUEsLETTER PDF

17.10.15

COMBINATORIAL CHEMISTRY IN A HISTORICAL PERSPECTIVE

Feature introducing the history and technological background of Nuevolution’s Chemetics platform. PDF

16.10.15

NUEsLETTER NO 1: LETTER FROM THE CEO

During my early years as industry medicinal chemist, I was fortunate enough to experience that hard work and bright minds by many, can overcome very difficult and important drug discovery challenges in the search for new medicines. I also realized that it required significant information generation in order to devise the optimal solutions, and that…